Increased serum TSH levels induce liver triglyceride accumulation, mainly via up-regulation of SREBP-1 stimulated by TSH receptors, resulting in induction of NAFLD [188]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.